436 results
8-K
EX-10.1
WINT
Windtree Therapeutics Inc
8 Apr 24
Entry into a Material Definitive Agreement
4:33pm
be sold, assigned or transferred pursuant to an exemption from such registration, or (C) such Buyer provides the Company with reasonable assurance … if the primary purpose or intent of the Person incurring such liability, or the primary effect thereof, is to provide assurance to the obligee
8-K
EX-2.1
2hvss 8wtsr
8 Apr 24
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-3.1
l4eoa
8 Apr 24
Entry into a Material Definitive Agreement
4:33pm
NT 10-K
pmkgzzylo
2 Apr 24
Notice of late annual filing
5:29pm
8-K
iu6jm bbs2mkluyiln
22 Jan 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:45pm
8-K
EX-1.1
i2ywx s4st
9 Nov 23
Windtree Therapeutics Reports Third Quarter 2023 Financial Results and Provides Key Business Updates
4:21pm
424B5
jz8 kvjy4de
9 Nov 23
Prospectus supplement for primary offering
4:11pm